)
Compugen (CGEN) investor relations material
Compugen KOL event summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Introduction and agenda
Event covered COM701 in ovarian cancer and the continued evolution of Unigen; no new targets were disclosed.
Interim MAIA-ovarian PFS analysis expected by Q1 2027.
KOL background and credentials
Dr. Oladapo Yeku, MAIA-ovarian lead investigator at Harvard and Massachusetts General Hospital, discussed ovarian cancer treatment and COM701’s maintenance rationale.
Market insights and analysis
Platinum sensitivity is defined by a platinum-free interval over six months; patients have more treatment options and longer survival than in platinum-resistant disease, though most eventually become resistant.
Bevacizumab is a maintenance option, but contraindications, prior use, side effects, or patient preference can lead to observation instead.
ADC maintenance trials are ongoing; efficacy results remain early, and added adverse effects and use of topoisomerase-1 payloads are concerns.
Second-line PARP inhibitor maintenance use was withdrawn by the FDA after toxicity and overall-survival concerns.
- AI-driven immuno-oncology pipeline advances with key AstraZeneca and Gilead partnerships.CGEN
Corporate presentation - Revenue doubled and clinical pipeline advanced, supporting a strong outlook into 2029.CGEN
Q2 2026 - Computationally driven immuno-oncology pipeline advances with key partnerships and adaptive trials.CGEN
24th Annual Needham Virtual Healthcare Conference - Rigorous computational discovery and validation drive novel immuno-oncology assets toward clinical success.CGEN
Fireside chat - AI-powered immuno-oncology pipeline advances with strong pharma partnerships and financial runway.CGEN
Stifel 2026 Targeted Oncology Virtual Forum - Up to $400M in securities offered to fund AI-driven cancer immunotherapy pipeline amid regional risks.CGEN
Registration filing - AI-powered immuno-oncology pipeline delivers novel antibodies and strong clinical progress.CGEN
Investor presentation - Strong cash reserves and advancing clinical pipeline support operations and milestones into 2029.CGEN
Q1 2026 - Computationally discovered immuno-oncology assets advance in pivotal trials and strategic partnerships.CGEN
Leerink’s Global Healthcare Conference 2025
Next Compugen earnings date
Next Compugen earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage
)